NDAQ
50
4
KHC
15
4
CNX
71
3
KIM
60
3
CMCSA
52
3
TGNA
50
2
CPB
27
5
TJX
54
6
WU
16
4
MCD
57
5
STI
35
14
ABBV
48
2
KO
46
4
IPG
42
2
PPL
47
3
CSX
43
3
BXP
41
3
MCK
59
3
ZION
52
3
MNST
52
6
NDAQ
50
4
KHC
15
4
CNX
71
3
KIM
60
3
CMCSA
52
3
TGNA
50
2
CPB
27
5
TJX
54
6
WU
16
4
MCD
57
5
STI
35
14
ABBV
48
2
KO
46
4
IPG
42
2
PPL
47
3
CSX
43
3
BXP
41
3
MCK
59
3
ZION
52
3
MNST
52
6
Financhill
Back

Theriva Biologics 10K Form

Buy
56

TOVX
Theriva Biologics

Last Price:
$1.71
Seasonality Move:
27.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.6M
Cash Flow: $-3.9M
Price / Cash Flow: 0
Annual Sales: $9.41
Price / Book: 0.2

Profitability

EPS (TTM): -33.18000
Net Income (TTM): $-26.7M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 12 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Buy
56
Theriva Biologics (TOVX) is a Buy

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Buy
    The current Theriva Biologics [TOVX] share price is $1.76. The Score for TOVX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.